article Open Access
Psychopharmacology of schizophrenia
International Journal of Pharmacognosy and Pharmaceutical Sciences · 2021 · Vol. 3(2) · pp. 28–30
Abstract
The revolution in psychopharmacology and biological psychiatry started by the introduction of chlorpromazine provided the first effective treatment for schizophrenia, as well as ideas and evidence about the pathophysiology of the illness. Brain imaging studies of receptor densities in young adults and children, or in patients with first-episode schizophrenia may be helpful in identifying early vulnerability factors.
Schizophrenia research and treatmentElectroconvulsive Therapy StudiesTreatment of Major DepressionSchizophrenia (object-oriented programming)PsychopharmacologyPsychiatryPsychologyVulnerability (computing)ChlorpromazineMedicineNeurosciencePharmacology
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
30%
vs. same field & year
Related articles
Psychopharmacology of schizophrenia
International Journal of Pharmacognosy and Pharmaceutical Sciences · 2021 · 0 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
